Home > Insider Trading > Filing (0001437749-24-006521)

Filing Details

Accession Number:: 0001437749-24-006521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-04 21:45:50
Reporting Period:: 2024-02-29

Accepted Time:: 2024-03-04 21:45:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158895	Lemaitre Vascular Inc	LMAT	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365737	W George Lemaitre	C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803	Chairman And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-02-29	1,300	$68.37	2,282,296	No	4	S	Direct
Common Stock	Disposition	2024-02-29	20,575	$69.69	2,261,721	No	4	S	Direct
Common Stock	Disposition	2024-02-29	5,984	$70.14	2,255,737	No	4	S	Direct
Common Stock	Disposition	2024-02-29	2	$0.00	2,255,735	No	4	M	Direct
Common Stock	Acquisiton	2024-02-29	5,828	$0.00	2,261,563	No	4	A	Direct
Common Stock	Acquisiton	2024-02-29	14	$0.00	2,261,577	No	4	M	Direct
Common Stock	Disposition	2024-02-29	432	$70.00	2,261,145	No	4	F	Direct
Common Stock	Disposition	2024-03-01	15,869	$67.51	2,245,276	No	4	S	Direct
Common Stock	Disposition	2024-03-01	20,200	$68.04	2,225,076	No	4	S	Direct
Common Stock	Disposition	2024-03-01	950	$69.64	2,224,126	No	4	S	Direct
Common Stock	Disposition	2024-03-04	32,800	$67.95	2,191,326	No	4	S	Direct
Common Stock	Disposition	2024-03-04	3,800	$68.68	2,187,526	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Dividend Equivalent Rights	Disposition	2024-02-29	15	$0.00	15	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
44			No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.98 to $68.95. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.00 to $69.98. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.00 to $70.61. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Represents shares from the release of fractional dividend equivalent rights returned to company.
These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $66.74 to $67.73. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.74 to $68.56. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.92 to $69.82. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.53 to $68.52. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.54 to $68.85. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.